Cargando…
Human Ace D/I Polymorphism Could Affect the Clinicobiological Course of COVID-19
INTRODUCTION: The coronavirus disease 2019 (COVID-19), that is caused by severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), has spread rapidly worldwide since December 2019. The SARS-CoV-2 virus has a great affinity for the angiotensin-converting enzyme-2 (ACE-2) receptor, which is an es...
Autores principales: | Aladag, Elifcan, Tas, Zahit, Ozdemir, Bilgesu Safak, Akbaba, Tayfun Hilmi, Akpınar, Meltem Gulsun, Goker, Hakan, Unalan-Altintop, Tugce, Inkaya, Ahmet Cagkan, Alp, Alpaslan, Metan, Gokhan, Haznedaroglu, Ibrahim Celalettin, Balci-Peynircioglu, Banu, Sayinalp, Nilgun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448604/ https://www.ncbi.nlm.nih.gov/pubmed/34603503 http://dx.doi.org/10.1155/2021/5509280 |
Ejemplares similares
-
Convalescent (immune) plasma treatment in a myelodysplastic COVID-19 patient with disseminated tuberculosis
por: Çınar, Olgu Erkin, et al.
Publicado: (2020) -
The clinical course of COVID-19 in hematopoietic stem cell transplantation (HSCT) recipients
por: KARATAŞ, Ayşe, et al.
Publicado: (2021) -
CD34+ hematopoietic progenitor cell dose as a predictor of engraftment and survival in multiple myeloma patients undergoing autologous stem cell transplantation
por: ALADAĞ, Elifcan, et al.
Publicado: (2020) -
The effects of blood group types on the risk of COVID-19 infection and its clinical outcome
por: GÖKER, Hakan, et al.
Publicado: (2020) -
Comparison of Myeloablative Versus Reduced-Intensity Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia: A Cohort Study
por: Çiftçiler, Rafiye, et al.
Publicado: (2019)